MannKind Corp (NASDAQ:MNKD)
| 3.68 Delayed Data As of May 20 |  +0.17 / +4.84%Today’s Change | 2.49 Today|||52-Week Range 5.53 | -15.79% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $929.4M |
Company Description
MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Contact Information
MannKind Corp. 1 Casper Street Danbury Connecticut 06810 |
Employees
Shareholders
| Individual stakeholders | 4.54% |
| Mutual fund holders | 23.60% |
| Other institutional | 21.51% |
Top Executives
| Michael E. Castagna | Chief Executive Officer & Director |
| Steven B. Binder | Chief Financial & Accounting Officer |
| Joseph Kocinsky | Chief Technology Officer |
| Kevin Kaiserman | Vice President-Medical Affairs & Safety |
| Thomas Hofmann | Chief Scientific Officer |
